Private Equity in 2026: Overcoming Exit Bottlenecks & Legacy Asset Drag

  • Private-equity firms enter 2026 with a large backlog of unsold assets, stretched hold periods, and aging dry powder, reflecting a still-clogged exit environment.
  • Improved 2025 exit and IPO activity was concentrated in a few high-quality deals, while weaker portfolio companies remain difficult to sell amid valuation mismatches and high rates.
  • Continuation vehicles have rapidly grown to about one-fifth of PE exits, easing liquidity pressure but intensifying concerns over conflicts of interest and valuation transparency.
  • General partners face rising pressure from limited partners to deliver liquidity and operational value creation as macro uncertainty, fundraising headwinds, and regulatory risks reshape PE strategies.
Read More

Going into 2026, private-equity firms face a dual challenge: managing legacy portfolios built during low rate, high valuation periods while adapting to external pressures that complicate both exits and new investments.

Backlog, valuation compression, and hold-period inflation. The unsold inventory in PE portfolios rose to about 12,900 U.S. companies as of September 30, 2025, slightly up from end-2024, with average hold periods still elevated at around seven years—well above pre-pandemic norms of about five years. The return distribution for older funds is increasingly bottlenecked as less desirable assets remain illiquid or underperforming, while valuation mismatches between seller expectations (often based on boom-era multiples) and buyer constraints (higher cost of capital, risk aversion) inhibit exits with acceptable IRRs [1][2][5].

Dry powder and deployment inertia. Despite $880 billion in undeployed U.S. capital and global dry powder having fallen from peaks, much of that capital is aging. Funds raised several years back are still seeking deployment. Meanwhile, deal volumes lag, as buyer-seller value and return expectations misalign. U.S. PE deal value rose about 8 % year-over-year in the first half of 2025, but deal counts stayed flat or declined—a signal that large deals are carrying the weight while smaller to mid-market opportunity remains constrained [2][5].

Exit mechanics and continued innovation. The rise in IPOs (e.g., Medline), major secondary takeouts (Ampere), and the growing use of continuation vehicles indicate that PE is expanding its exit toolbox. However, continuation vehicles, which allow GPs to retain assets while returning capital to LPs, have jumped from ~12–13 % of exits in 2024 to ~20 % in 2025 (~$107 billion), drawing scrutiny over potential conflicts of interest and valuation transparency [3].

Strategic implications for GPs and LPs. General partners must balance portfolio clean-ups with preserving IRR and fee streams. LPs are increasingly sensitive to distribution shortfalls and delayed liquidity, especially with older funds aging past their expected life cycles [4]. Firms adept at operational value creation, flexible exit structures, and selective asset quality will likely outperform. Macro conditions—interest rates, trade/tariff policies, regulatory oversight—remain key tailwinds or headwinds.

Open questions. • Will interest rates materially decline in 2026 to unlock exit multiples and debt-financed deals?
• How will LPs respond to extended fund lifespans and pressure for liquidity—will there be more redemptions or rebalances away from traditional PE?
• Will regulatory bodies impose tighter standards around valuation and continuation vehicles?
• Which sectors will yield the next wave of IPOs or buyer-demand to clear the backlog?

Supporting Notes
  • 12,900 U.S. companies in PE portfolios as of September 30, 2025, up slightly from end-2024; average hold-period near seven years. [1]
  • Undeployed U.S. PE capital about $880 billion as of September 2025, down from record $1.3 trillion in December 2024. [1][2]
  • Global exit value (sales + IPOs) rose over 40 % in 2025 through Dec 22, though still concentrated among large, high-quality assets. [1][2]
  • Medline IPO (largest since 2021) and Ampere Computing sale for $6.5 billion were among the biggest exits. [1]
  • Continuation vehicle exits now represent ~20 % of PE sales (~$107 billion), up from ~12-13 % in the prior year. [3]
  • First half of 2025 saw deal value up ~8 % year-over-year in U.S.; volume flat or slightly down. U.S. fundraising down significantly: traditional commingled fund commitments off 24 % YoY. [2]
  • Distribution rates remain depressed especially in older vintages; NAV for late-life funds rising while cash flows to LPs lag, per MSCI data. [4]
  • Carve-outs constituted ~10.6 % of U.S. buyout deals in 1H 2025, above 5-year average of 8.7 %; exit count and value fell sharply in Q2. [7]

Sources

      [1] www.wsj.com (The Wall Street Journal) — December 28, 2025
      [3] www.ft.com (Financial Times) — December 30, 2025

Leave a Comment

Your email address will not be published. Required fields are marked *

Search
Filters
Clear All
Quick Links
Scroll to Top